Display options
Cite
Kesavarapu K, Kang M, Shin JJ, et al. Yogi Detox Tea: A Potential Cause of Acute Liver Failure. Case Rep Gastrointest Med. 2017;2017:3540756doi: 10.1155/2017/3540756.
Kesavarapu, K., Kang, M., Shin, J. J., & Rothstein, K. (2017). Yogi Detox Tea: A Potential Cause of Acute Liver Failure. Case reports in gastrointestinal medicine, 20173540756. https://doi.org/10.1155/2017/3540756
Kesavarapu, Keerthana, et al. "Yogi Detox Tea: A Potential Cause of Acute Liver Failure." Case reports in gastrointestinal medicine vol. 2017 (2017): 3540756. doi: https://doi.org/10.1155/2017/3540756
Kesavarapu K, Kang M, Shin JJ, Rothstein K. Yogi Detox Tea: A Potential Cause of Acute Liver Failure. Case Rep Gastrointest Med. 2017;2017:3540756. doi: 10.1155/2017/3540756. Epub 2017 Oct 24. PMID: 29204300; PMCID: PMC5674495.
Copy Download .nbib Format: NLM
Share it on

Case Rep Gastrointest Med. 2017;2017:3540756. doi: 10.1155/2017/3540756. Epub 2017 Oct 24.

Yogi Detox Tea: A Potential Cause of Acute Liver Failure.

Case reports in gastrointestinal medicine

Keerthana Kesavarapu, Mitchell Kang, Jaewook James Shin, Kenneth Rothstein

Affiliations

  1. Department of Internal Medicine, Drexel University Hospital, Philadelphia, PA, USA.
  2. Drexel School of Medicine, Philadelphia, PA, USA.
  3. Department of Gastroenterology, Drexel University Hospital, Philadelphia, PA, USA.
  4. Department of Hepatology, Drexel University Hospital, Philadelphia, PA, USA.

PMID: 29204300 PMCID: PMC5674495 DOI: 10.1155/2017/3540756

Abstract

We present a case of acute fulminant liver failure from a liver detoxification tea. We present a 60-year-old female with weakness, lethargy, scleral icterus, jaundice, and worsening mental status. She drank herbal tea three times a day for 14 days prior to symptom development. Liver tests were elevated. Remaining laboratory tests and imaging were negative for other etiologies. An ultrasound-guided liver biopsy showed submassive necrosis. A literature search on the ingredients shows six ingredients as having hepatotoxic effects and remaining ingredients as having very sparse hepatoprotective data. Healthcare professionals should discuss herbal medication and tea use and report adverse effects.

References

  1. Xenobiotica. 2015 Apr;45(4):361-72 - PubMed
  2. World J Hepatol. 2012 Jul 27;4(7):231-3 - PubMed
  3. Zhongguo Zhong Yao Za Zhi. 2011 Oct;36(19):2610-4 - PubMed
  4. Aliment Pharmacol Ther. 2013 Jan;37(1):3-17 - PubMed
  5. Hepatology. 2012 Mar;55(3):965-7 - PubMed
  6. J Ethnopharmacol. 2011 Mar 24;134(2):216-20 - PubMed
  7. Zhongguo Zhong Yao Za Zhi. 2006 Jul;31(13):1091-3 - PubMed
  8. J Nat Prod. 2009 Jun;72(6):1161-4 - PubMed
  9. Pharmacotherapy. 2010 Jul;30(7):750, 258e-262e - PubMed
  10. Int J Mol Sci. 2015 Dec 24;17 (1):null - PubMed
  11. Zhongguo Zhong Yao Za Zhi. 2013 Jul;38(14):2365-9 - PubMed
  12. Toxicol Lett. 1988 Nov;44(1-2):177-82 - PubMed
  13. Case Reports Hepatol. 2013;2013:965092 - PubMed
  14. Evid Based Complement Alternat Med. 2014;2014:872320 - PubMed
  15. J Ethnopharmacol. 2009 Jul 6;124(1):18-25 - PubMed
  16. Yao Xue Xue Bao. 2009 Aug;44(8):885-90 - PubMed
  17. J Proteome Res. 2014 Dec 5;13(12 ):5724-33 - PubMed
  18. Liver Int. 2014 Apr;34(4):583-93 - PubMed
  19. Hepatology. 2014 Oct;60(4):1399-408 - PubMed
  20. Food Chem Toxicol. 2011 Aug;49(8):1820-7 - PubMed
  21. Ann Intern Med. 2002 Dec 17;137(12):947-54 - PubMed
  22. Rev Esp Enferm Dig. 2005 Feb;97(2):115-24 - PubMed
  23. Phytomedicine. 2015 Dec 1;22(13):1201-5 - PubMed
  24. Front Pharmacol. 2016 Jun 20;7:174 - PubMed
  25. Nat Prod Res. 2013;27(10):929-33 - PubMed
  26. Infect Disord Drug Targets. 2015;15(2):131-4 - PubMed

Publication Types